KIT and breast cancer: Taken together, these results reveal an increased frequency of peripheral blood CD117+ granulocytes in non-metastatic BC patients at time of diagnosis, as well as significant changes in the frequency of myeloid and lymphocytic cell populations expressing unconventional marker combinations.